SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medico Remedies - Quaterly Results

08 May 2025 Evaluate
The revenue slipped marginally during the March 2025 quarter. A decline of about Rs. 413.03 millions was observed as compared to Rs. 413.23 millions during the corresponding quarter last year.A comparatively good net profit growth of 40.01% to Rs. 43.39 millions was reported for the quarter ended March 2025 compared to Rs. 30.99 millions of previous same quarter.OP of the company witnessed a marginal growth to 69.57 millions from 52.30 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 413.03 413.23 -0.05 1509.41 1449.21 4.15 1509.41 1449.21 4.15
Other Income 2.93 5.84 -49.83 26.89 21.28 26.36 26.89 21.28 26.36
PBIDT 69.57 52.30 33.02 176.93 150.38 17.66 176.93 150.38 17.66
Interest 4.94 2.47 100.00 11.58 8.24 40.53 11.58 8.24 40.53
PBDT 64.63 49.83 29.70 165.35 142.14 16.33 165.35 142.14 16.33
Depreciation 7.66 7.38 3.79 30.30 28.79 5.24 30.30 28.79 5.24
PBT 56.97 42.45 34.20 135.05 113.35 19.14 135.05 113.35 19.14
TAX 13.58 11.46 18.50 34.11 30.44 12.06 34.11 30.44 12.06
Deferred Tax -5.19 -0.46 1028.26 -3.92 -1.22 221.31 -3.92 -1.22 221.31
PAT 43.39 30.99 40.01 100.94 82.91 21.75 100.94 82.91 21.75
Equity 165.97 165.97 0.00 165.97 165.97 0.00 165.97 165.97 0.00
PBIDTM(%) 16.84 12.66 33.09 11.72 10.38 12.96 11.72 10.38 12.96

Medico Remedies Share Price

41.24 1.77 (4.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×